SymBiosis Capital Partners, LLC
CIK: 0002006045SEC EDGAR →
Portfolio Value
$109.5M
Holdings
11
As of
Q4 2025
New Positions
11
Closed Positions
0
Portfolio Value History
No historical data available yet. Chart will appear after multiple quarterly filings.
Top 10 Holdings
| Rank | Stock | Shares | Value | % of Portfolio |
|---|---|---|---|---|
| 1 | Evommune, Inc. | 1,280,778 | $21.9M | 20.02% |
| 2 | Verastem Inc | 2,000,000 | $15.4M | 14.10% |
| 3 | Aldeyra Therapeutics Inc | 2,555,000 | $13.2M | 12.09% |
| 4 | Precigen Inc | 3,000,000 | $12.5M | 11.45% |
| 5 | Inventiva S.A. | 2,600,000 | $12.1M | 11.04% |
| 6 | Nuvation Bio Inc | 1,250,000 | $11.2M | 10.23% |
| 7 | Rani Therapeutics Holdings, Inc. | 6,300,000 | $8.5M | 7.77% |
| 8 | Aardvark Therapeutics, Inc. | 476,595 | $6.3M | 5.71% |
| 9 | Clene Nanomedicine Inc. | 770,495 | $4.5M | 4.13% |
| 10 | Generation Bio Co | 665,000 | $3.8M | 3.45% |
Sector Breakdown
| Sector | # Holdings | Value | % |
|---|---|---|---|
| Healthcare | 10 | $96.3M | 87.9% |
| Technology | 1 | $13.2M | 12.1% |